AKI stage 1 | AKI stage 2 | AKI stage 3 | AKI no CKD | AKI on CKD | CKD no AKI | |
---|---|---|---|---|---|---|
pSCr (μmol/L) | n / deaths (%) | n / deaths (%) | n / deaths (%) | n / deaths (%) | n / deaths (%) | n / deaths (%) |
≤100 | 3,861 / 342 (8.9%) | 458 / 80 (17.5%) | 68 / 17 (25.0%) | 4,335 / 433 (10.0%) | 52 / 6 (11.5%) | 1,594 / 41 (2.6%) |
101–200 | 4,331 / 633 (14.6%) | 1,475 / 367 (24.9%) | 434 / 125 (28.8%) | 5,684 / 1,018 (17.9%) | 556 / 107 (19.2%) | 3,944 / 141 (3.6%) |
201–300 | 842 / 186 (22.1%) | 547 / 176 (32.2%) | 301 / 102 (33.9%) | 1,288 / 370 (28.7%) | 402 / 94 (23.4%) | 782 / 37 (4.7%) |
301–400 | 185 / 42 (22.7%) | 132 / 42 (31.8%) | 337 / 110 (32.6%) | 443 / 145 (32.7%) | 211 / 49 (23.2%) | 200 / 12 (6.0%) |
>400 | 120 / 15 (12.5%) | 2 / 0 (0.0%) | 742 / 194 (26.1%) | 530 / 150 (28.3%) | 334 / 59 (17.7%) | 254 / 13 (5.1%) |
AKI = acute kidney injury; CKD = chronic kidney disease; pSCr = peak serum creatinine.